- Home
- PLRZ vs GELS Comparison
PLRZ vs GELS Comparison
Compare PLRZ & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- GELS
- Stock Information
- Founded
- PLRZ 2005
- GELS 2018
- Country
- PLRZ Israel
- GELS Australia
- Employees
- PLRZ N/A
- GELS N/A
- Industry
- PLRZ
- GELS
- Sector
- PLRZ
- GELS
- Exchange
- PLRZ NYSE
- GELS NYSE
- Market Cap
- PLRZ 14.7M
- GELS 15.8M
- IPO Year
- PLRZ 2024
- GELS 2024
- Fundamental
- Price
- PLRZ $0.01
- GELS $1.69
- Analyst Decision
- PLRZ
- GELS
- Analyst Count
- PLRZ 0
- GELS 0
- Target Price
- PLRZ N/A
- GELS N/A
- AVG Volume (30 Days)
- PLRZ 77.7M
- GELS 4.7M
- Earning Date
- PLRZ 02-15-2025
- GELS 02-15-2025
- Dividend Yield
- PLRZ N/A
- GELS N/A
- EPS Growth
- PLRZ N/A
- GELS N/A
- EPS
- PLRZ N/A
- GELS N/A
- Revenue
- PLRZ N/A
- GELS $95,618.00
- Revenue This Year
- PLRZ N/A
- GELS N/A
- Revenue Next Year
- PLRZ N/A
- GELS N/A
- P/E Ratio
- PLRZ N/A
- GELS N/A
- Revenue Growth
- PLRZ N/A
- GELS N/A
- 52 Week Low
- PLRZ $0.25
- GELS $0.77
- 52 Week High
- PLRZ $4.80
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- GELS N/A
- Support Level
- PLRZ N/A
- GELS N/A
- Resistance Level
- PLRZ N/A
- GELS N/A
- Average True Range (ATR)
- PLRZ 0.00
- GELS 0.00
- MACD
- PLRZ 0.00
- GELS 0.00
- Stochastic Oscillator
- PLRZ 0.00
- GELS 0.00
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.